Cadrenal Therapeutics, Inc. Common Stock
CVKD · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $28,269 | $23,638 | $32,511 | $22,097 |
| - Cash | $3,860 | $5,571 | $7,336 | $10,018 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $24,409 | $18,067 | $25,175 | $12,079 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | $0 | -$6 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$2,685 | -$3,734 | -$3,840 | -$4,187 |
| % Margin | – | – | – | – |
| Net Income | -$2,686 | -$3,667 | -$3,845 | -$4,187 |
| % Margin | – | – | – | – |
| EPS Diluted | -1.31 | -1.87 | -2.09 | -2.75 |
| % Growth | 29.9% | 10.5% | 24% | – |
| Operating Cash Flow | -$2,357 | -$3,026 | -$4,649 | -$1,791 |
| Capital Expenditures | -$2 | $0 | -$3 | -$7 |
| Free Cash Flow | -$2,359 | -$3,026 | -$4,652 | -$1,797 |